Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-26-001217
Accepted
2026-04-17 00:15:15
Documents
1
Effectiveness Date
2026-04-16

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-26-001217.txt   1751
Mailing Address 180 THIRD AVENUE 4TH FLOOR WALTHAM MA 02451
Business Address 180 THIRD AVENUE 4TH FLOOR WALTHAM MA 02451 508-440-9475
Kailera Therapeutics, Inc. (Filer) CIK: 0002096997 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-294690 | Film No.: 26869298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)